Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01495429 · ClinicalTrials.gov registry record · Phase 3

Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurological Intensive Care

A Phase 3 study, sponsored by University of Michigan.

Completed
Registry status
Phase 3
Development phase
80
Enrollment target

NCT01495429: Completed Phase 3 study, sponsored by University of Michigan.

NCT01495429 is a Phase 3 study that has completed, run by University of Michigan. The registered enrollment target is 80 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01495429, a Phase 3 study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
Phase 3
Development phase
80 participants
Enrollment target

Study Summary

The investigators aim to compare the complications between centrally and peripherally inserted central venous catheters in neurological intensive care unit patients. The study hypothesis is that peripherally inserted catheters will have more cumulative complications due to venous thrombosis.

Interventions

  • PROCEDURE Central venous catheter

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2012-01
Est. Completion 2015-07
Phase Phase 3
University of Michigan

1,327 total trials

What the finished NCT01495429 record still lists

NCT01495429 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 1 intervention - of which Central venous catheter is the first listed.

NCT01495429 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01495429 about?

NCT01495429 is a clinical study titled "Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurological Intensive Care". The investigators aim to compare the complications between centrally and peripherally inserted central venous catheters in neurological intensive care unit patients. The study hypothesis is that peripherally inserted catheters will have more cumulative complications due to venous thrombosis.

What is the current status of trial NCT01495429?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 80 participants. The study started on 2012-01. Estimated completion is 2015-07.

What interventions are being tested in trial NCT01495429?

The interventions under investigation include: Central venous catheter (PROCEDURE).

Who is sponsoring clinical trial NCT01495429?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01495429's enrollment target sits among peer trials

80 1755th of 2000 higher than 233 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01495429, the US trial registry maintained by the National Library of Medicine. NCT01495429 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.